Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-11

Clinical Trial Update: Precision Treatment With Angiotensin Converting Enzyme Inhibitor [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating precision treatment with an ACE inhibitor in hypertension; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACE inhibitor (angiotensin-converting enzyme inhibitor)

Snippet

Sponsor: Yonsei University | Conditions: Hypertension | Phase 4 | Status: COMPLETED